4
Changes in Ownership
Fulgent Genetics, Inc. Filed Acc 0001209191-22-014738
Chief Scientific Officer acquired 41,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gao Hanlin · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-28 | Grant or award : show line 1 in the form | +9,000 | 824,345 | D |
| 2022-02-28 | Grant or award : show line 2 in the form | +32,000 | 856,345 | D |
Loading xslF345X03/doc4.xml…